CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells
<p>Abstract</p> <p>Background</p> <p>Recognition of repeat unmethylated CpG motifs from bacterial DNA through Toll-like receptor (TLR-9) has been shown to induce interleukin (IL)-8 expression in immune cells. We sought to investigate the role of CpG oligodeoxynucleotide...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-06-01
|
Series: | Respiratory Research |
Online Access: | http://respiratory-research.com/content/7/1/84 |
id |
doaj-16134c8adba34307b7b0457eeb03e014 |
---|---|
record_format |
Article |
spelling |
doaj-16134c8adba34307b7b0457eeb03e0142020-11-25T01:39:17ZengBMCRespiratory Research1465-99212006-06-01718410.1186/1465-9921-7-84CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cellsWong Hector RLierl Kristin MHughes Valerie SParilla N WilliamPage Kristen<p>Abstract</p> <p>Background</p> <p>Recognition of repeat unmethylated CpG motifs from bacterial DNA through Toll-like receptor (TLR-9) has been shown to induce interleukin (IL)-8 expression in immune cells. We sought to investigate the role of CpG oligodeoxynucleotides (ODN) on a human bronchial epithelial cells.</p> <p>Methods</p> <p>RT-PCR and Western blot analysis were used to determine expression of TLR-9 in human bronchial epithelial cells (16HBE14o-). Cells were treated with CpG ODN in the presence or absence of IL-1β and IL-8 protein was determined using ELISA. In some cases cells were pretreated with chloroquine, an inhibitor of TLR-9 signaling, or SB202190, an inhibitor of the mitogen activated protein kinase p38, prior to treatment with IL-1β and CpG. TLR9 siRNA was used to silence TLR9 prior to treatment with IL-1β and CpG. IκBα and p38 were assessed by Western blot, and EMSA's were performed to determine NF-κB activation. To investigate IL-8 mRNA stability, cells were treated with IL-1β in the absence or presence of CpG for 2 h and actinomycin D was added to induce transcriptional arrest. Cells were harvested at 15 min intervals and Northern blot analysis was performed.</p> <p>Results</p> <p>TLR-9 is expressed in 16HBE14o- cells. CpG synergistically increased IL-1β-induced IL-8 protein abundance, however treatment with CpG alone had no effect. CpC (a control ODN) had no effect on IL-1β-induced IL-8 levels. In addition, CpG synergistically upregulated TNFα-induced IL-8 expression. Silencing TLR9 using siRNA or pretreatment of cells with chloroquine had little effect on IL-1β-induced IL-8 levels, but abolished CpG-induced synergy. CpG ODN had no effect on NF-κB translocation or DNA binding in 16HBE14o- cells. Treatment with CpG increased phosphorylation of p38 and pretreatment with the p38 inhibitor SB202190 attenuated the synergistic increase in IL-8 protein levels. Analysis of the half-life of IL-8 mRNA revealed that IL-8 mRNA had a longer half-life following the co-treatment of CpG and IL-1β compared to treatment with IL-1β alone.</p> <p>Conclusion</p> <p>Together, these data demonstrate that CpG modulates IL-8 synthesis in the presence of a pro-inflammatory mediator utilizing TLR9 and post-transcriptional mechanisms involving the activation of p38 and stabilization of IL-8 mRNA.</p> http://respiratory-research.com/content/7/1/84 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wong Hector R Lierl Kristin M Hughes Valerie S Parilla N William Page Kristen |
spellingShingle |
Wong Hector R Lierl Kristin M Hughes Valerie S Parilla N William Page Kristen CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells Respiratory Research |
author_facet |
Wong Hector R Lierl Kristin M Hughes Valerie S Parilla N William Page Kristen |
author_sort |
Wong Hector R |
title |
CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells |
title_short |
CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells |
title_full |
CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells |
title_fullStr |
CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells |
title_full_unstemmed |
CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells |
title_sort |
cpg dna modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16hbe14o-) cells |
publisher |
BMC |
series |
Respiratory Research |
issn |
1465-9921 |
publishDate |
2006-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Recognition of repeat unmethylated CpG motifs from bacterial DNA through Toll-like receptor (TLR-9) has been shown to induce interleukin (IL)-8 expression in immune cells. We sought to investigate the role of CpG oligodeoxynucleotides (ODN) on a human bronchial epithelial cells.</p> <p>Methods</p> <p>RT-PCR and Western blot analysis were used to determine expression of TLR-9 in human bronchial epithelial cells (16HBE14o-). Cells were treated with CpG ODN in the presence or absence of IL-1β and IL-8 protein was determined using ELISA. In some cases cells were pretreated with chloroquine, an inhibitor of TLR-9 signaling, or SB202190, an inhibitor of the mitogen activated protein kinase p38, prior to treatment with IL-1β and CpG. TLR9 siRNA was used to silence TLR9 prior to treatment with IL-1β and CpG. IκBα and p38 were assessed by Western blot, and EMSA's were performed to determine NF-κB activation. To investigate IL-8 mRNA stability, cells were treated with IL-1β in the absence or presence of CpG for 2 h and actinomycin D was added to induce transcriptional arrest. Cells were harvested at 15 min intervals and Northern blot analysis was performed.</p> <p>Results</p> <p>TLR-9 is expressed in 16HBE14o- cells. CpG synergistically increased IL-1β-induced IL-8 protein abundance, however treatment with CpG alone had no effect. CpC (a control ODN) had no effect on IL-1β-induced IL-8 levels. In addition, CpG synergistically upregulated TNFα-induced IL-8 expression. Silencing TLR9 using siRNA or pretreatment of cells with chloroquine had little effect on IL-1β-induced IL-8 levels, but abolished CpG-induced synergy. CpG ODN had no effect on NF-κB translocation or DNA binding in 16HBE14o- cells. Treatment with CpG increased phosphorylation of p38 and pretreatment with the p38 inhibitor SB202190 attenuated the synergistic increase in IL-8 protein levels. Analysis of the half-life of IL-8 mRNA revealed that IL-8 mRNA had a longer half-life following the co-treatment of CpG and IL-1β compared to treatment with IL-1β alone.</p> <p>Conclusion</p> <p>Together, these data demonstrate that CpG modulates IL-8 synthesis in the presence of a pro-inflammatory mediator utilizing TLR9 and post-transcriptional mechanisms involving the activation of p38 and stabilization of IL-8 mRNA.</p> |
url |
http://respiratory-research.com/content/7/1/84 |
work_keys_str_mv |
AT wonghectorr cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells AT lierlkristinm cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells AT hughesvaleries cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells AT parillanwilliam cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells AT pagekristen cpgdnamodulatesinterleukin1binducedinterleukin8expressioninhumanbronchialepithelial16hbe14ocells |
_version_ |
1725049539050602496 |